Ambee Pharmaceuticals PLC announcements
253 Dhaka Stock Exchange announcements for Ambee Pharmaceuticals PLC (AMBEEPHA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (15).
- Qualified Opinion and Emphasis of Matter
The auditor of the company has given the Qualified Opinion and Emphasis of Matter in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/AMBEEPHA_2025.pdf
- Credit Rating Result
ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A" for long term and "ST-2" for short term along with Stable outlook in consideration of audited financials of the company up to June 30, 2024 and unaudited financials up to the period ending September 30, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after Record Date
Trading of the shares of the company will resume on 23.11.2025.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 20.11.2025.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 18.11.2025 to 19.11.2025 and trading of the shares will remain suspended on record date i.e., 20.11.2025.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.50 for July-September 2025 as against Tk. 0.70 for July-September 2024. NOCFPS was Tk. (9.28) for July-September 2025 as against Tk. (6.43) for July-September 2024. NAV per share was Tk. 13.97 as on September 30, 2025 and Tk. 13.47 as on June 30, 2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2025 at 3:00 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Dividend Declaration
The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2025. Date of AGM: 18.12.2025, Time: 11:00 AM, Venue: Online/Digital Platform (184/1, Tejgaon Industrial Area, Dhaka-1208). Record Date: 20.11.2025. The Company has also reported EPS of Tk. 2.21, NAV per share of Tk. 13.47, and NOCFPS of Tk. 9.06 for the year ended June 30, 2025, as against EPS of Tk. 4.03, NAV per share of Tk. 12.26, and NOCFPS of Tk. (27.47) for the year ended June 30, 2024.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (02.11.2025) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2025.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.85 for January-March 2025 as against Tk. 0.80 for January-March 2024; EPS was Tk. 2.17 for July 2024-March 2025 as against Tk. 2.00 for July 2023-March 2024. NOCFPS was Tk. (5.69) for July 2024-March 2025 as against Tk. (12.21) for July 2023-March 2024. NAV per share was Tk. 13.43 as on March 31, 2025 and Tk. 12.26 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.62 for October-December 2024 as against Tk. 0.60 for October-December 2023; EPS was Tk. 1.32 for July-December 2024 as against Tk. 1.20 for July-December 2023. NOCFPS was Tk. (19.54) for July-December 2024 as against Tk. (5.61) for July-December 2023. NAV per share was Tk. 12.58 as on December 31, 2024 and Tk. 12.26 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 22, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.